SLC11A2 and ovarian cancer: Data from two independent GENT microarray platforms showed that SLC11A2 transcript levels were significantly increased in ovarian cancer compared with normal ovarian tissue (GPL570, P < 0.001, Log2FC = 0.207; GPL96, P < 0.001, Log2FC = 0.399).